Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Marko Jakopović

19929

Marko

Jakopović

izv. prof. dr. sc.

Naziv Uloga Akcije
Reprogramiranje citoprotektivnih puteva u mezoteliomu suradnik
Naziv Akcije
Šimić, Vesna; Harabajsa, Suzana; Vrabec Branica; Božica; Kuhtić, Ivana; Žižić, David Stipan; Jakopović, Marko; Smojver-Ježek, Silvana CT-guided transthoracic needle procedures-accuracy and safety of cytology // Cytopathology, 34/2023 (2023), S1; 1-59
Harabajsa, Suzana ; Šefčić, Hajdi ; Klasić, Marija ; Milavić, Marija ; Židovec Lepej, Snježana ; Grgić, Ivana ; Zajc Petranović, Matea ; Jakopović, Marko ; Smojver-Ježek, Silvana ; Korać, Petra Infection with human cytomegalovirus, Epstein- Barr virus, and high-risk types 16 and 18 of human papillomavirus in EGFR-mutated lung adenocarcinoma // Croatian medical journal, 64 (2023), 84-92. doi: 10.3325/cmj.2023.64.84
Harabajsa, Suzana; Gršković, Paula; Begić, Valerija; Milutin, Lucija; Krupec, Ana-Marija; Vranjković, Marijana; Šimić, Vesna; Vrabec Branica, Božica; Bubanović, Gordana; Lukić Franolić, Ivana et al. Molecular analysis of immune response in EGFR-positive lung adenocarcinoma // Cytopathology, 34/2023 (2023), S1; 1-59
Bitar, Lela ; Seiwerth, Fran ; Ljubicic, Lidija ; Srdic, Drazena ; Bacelic-Gabelica, Ana ; Maletic, Olivera ; Popović, Filip ; Dzubur, Fedza ; Korsic, Marta ; Badovinac, Sonja et al. Systemic inflammation markers ratio in heavily pretreated NSCLC patients treated with nivolumab. // Journal of clinical oncology, 41 (2023), 16_suppl; e21188-e21188. doi: 10.1200/jco.2023.41.16_suppl.e21188
Harabajsa, Suzana ; Gršković, Paula ; Begić, Valerija ; Milutin, Lucija ; Krupec, Ana-Marija ; Vranjković, Marijana ; Šimić, Vesna ; Vrabec Branica, Božica ; Bubanović, Gordana ; Lukić Franolić, Ivana et al. CXCR4 AND IL-1β GENE EXPRESSION IN LUNG ADENOCARCINOMA CYTOLOGY. 2023. str. 1-2
Čerina, Dora ; Krpina, Kristina ; Jakopović, Marko ; Dedić Plavetić, Natalija ; Seiwerth, Fran ; Tomić, Snježana ; Radić, Jasna ; Belac Lovasić, Ingrid ; Canjko, Ivana ; Boban, Marijo et al. The Challenges and Opportunities of the Implementation of Comprehensive Genomic Profiling in Everyday Clinical Practice with Non-Small Cell Lung Cancer: National Results from Croatia // Cancers, 15 (2023), 13; 3395, 11. doi: 10.3390/cancers15133395
Harabajsa, Suzana ; Šimić, Vesna ; Vrabec Branica, Božica ; Badovinac, Sonja ; Jakopović, Marko ; Smojver- Ježek, Silvana Predictive immunocytochemistry in non-small cell lung cancer cytological samples // Molecular and experimental biology in medicine, 4 (2022), 1; 15-20. doi: 10.33602/mebm.4.1.3
Trivanović, Dragan ; Peršurić, Željka ; Agaj, Andrea ; Jakopović, Marko ; Samaržija, Miroslav ; Bitar, Lela ; Pavelić, Krešimir The interplay of lung cancer, COVID-19, and vaccines // International journal of molecular sciences, 23 (2022), 23; 15067, 15. doi: 10.3390/ijms232315067
Karabatić, Sandra ; Šajnić, Andreja ; Pleština, Sanja ; Jakopović, Marko ; Kurtović, Biljana Croatian National Cancer Patient Experience Survey // International journal of environmental research and public health, 19 (2022), 14; 8285, 9. doi: 10.3390/ijerph19148285
Baranašić, Jurica ; Šutić, Maja ; Catalano, Calogerina ; Drpa, Gordana ; Huhn, Stefanie ; Majhen, Dragomira ; Nestić, Davor ; Kurtović, Matea ; Rumora, Lada ; Bosnar, Martina et al. TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line // Biomedicines, 10 (2022), 9; 2240, 23. doi: 10.3390/biomedicines10092240
nije evidentirano
nije evidentirano